Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) (IMA)
Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) is the official source of medicine shortage information for Iceland (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- lyfjastofnun.is
- Country
- Iceland
- Notices tracked by Mederti
- 3,345
- Last checked
- 31 Oct 2026
Latest notices from IMA
- Desogestrelum — active, medium, since 31 Oct 2026 (source)
- Gliclazidum — active, medium, since 31 Oct 2026 (source)
- Lacosamidum — active, medium, since 31 Oct 2026 (source)
- Blanda — active, medium, since 30 Oct 2026 (source)
- Ramiprilum — active, medium, since 30 Oct 2026 (source)
- Mercaptaminum — active, medium, since 30 Oct 2026 (source)
- Lacosamidum — active, medium, since 30 Oct 2026 (source)
- Metronidazolum — active, medium, since 30 Oct 2026 (source)
- Blanda — active, low, since 29 Oct 2026 (source)
- Dextran 40 — active, medium, since 29 Oct 2026 (source)
- Carvedilolum — active, medium, since 29 Oct 2026 (source)
- Vinorelbinum — active, low, since 28 Oct 2026 (source)
- Propofolum — active, medium, since 28 Oct 2026 (source)
- Mirtazapinum — active, medium, since 28 Oct 2026 (source)
- Losartanum — active, low, since 28 Oct 2026 (source)
Every IMA notice, searchable and alertable
Search Iceland's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency). All notices remain the property of their publisher and are linked to the original source.